Virtual screening on large scale grids

Large scale grids for in silico drug discovery open opportunities of particular interest to neglected and emerging diseases. In 2005 and 2006, we have been able to deploy large scale virtual docking within the framework of the WISDOM initiative against malaria and avian influenza requiring about 100 years of CPU on the EGEE, Auvergrid and TWGrid infrastructures. These achievements demonstrated the relevance of large scale grids for the virtual screening by molecular docking. This also allowed evaluating the performances of the grid infrastructures and to identify specific issues raised by large scale deployment.

[1]  Y. Guan,et al.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.

[2]  Martin Hofmann,et al.  Grid Added Value to Address Malaria , 2006, CCGRID.

[3]  Tom L. Blundell,et al.  Keynote review: Structural biology and drug discovery , 2005 .

[4]  M L Lamb,et al.  Computational approaches to molecular recognition. , 1997, Current opinion in chemical biology.

[5]  J. An,et al.  Structure-based virtual screening of chemical libraries for drug discovery. , 2006, Current opinion in chemical biology.

[6]  Flavia Donno,et al.  Analysis of the ATLAS Rome production experience on the LHC computing grid , 2005, First International Conference on e-Science and Grid Computing (e-Science'05).

[7]  R E Cachau,et al.  Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[9]  C. Curtis,et al.  The Case for Deemphasizing Genomics in Malaria Control , 2000, Science.

[10]  R. Spencer,et al.  High-throughput screening of historic collections: observations on file size, biological targets, and file diversity. , 1998, Biotechnology and bioengineering.

[11]  Jochen Wiesner,et al.  New antimalarial drugs. , 2003, Angewandte Chemie.

[12]  N. Jacq,et al.  Grid-Enabled High-Throughput In Silico Screening Against Influenza A Neuraminidase , 2006, IEEE Transactions on NanoBioscience.

[13]  Ian Foster,et al.  Grid technologies empowering drug discovery. , 2002, Drug discovery today.

[14]  Johan Montagnat,et al.  Grid-enabled Virtual Screening Against Malaria , 2006, Journal of Grid Computing.

[15]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[16]  Solomon Nwaka,et al.  Science & society: Virtual drug discovery and development for neglected diseases through public–private partnerships , 2003, Nature Reviews Drug Discovery.

[17]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[18]  William Gropp,et al.  Dynamic process management in an MPI setting , 1995, Proceedings.Seventh IEEE Symposium on Parallel and Distributed Processing.

[19]  Krishnarao Appasani Continuing the 'ome' revolution. , 2002, Drug discovery today.

[20]  D. Sullivan,et al.  Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. , 1997, Annual review of microbiology.

[21]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[22]  Marc Zimmermann,et al.  Demonstration of In Silico Docking at a Large Scale on Grid Infrastructure , 2006, HealthGrid.

[23]  J.T. Moscicki DIANE - distributed analysis environment for GRID-enabled simulation and analysis of physics data , 2003, 2003 IEEE Nuclear Science Symposium. Conference Record (IEEE Cat. No.03CH37515).

[24]  David Abramson,et al.  The Virtual Laboratory: a toolset to enable distributed molecular modelling for drug design on the World‐Wide Grid , 2003, Concurr. Comput. Pract. Exp..

[25]  T. Blundell,et al.  Structural biology and drug discovery. , 2005, Drug discovery today.

[26]  D. Goldberg,et al.  Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. , 2001, Trends in parasitology.

[27]  Hiroshi Nakamura,et al.  Grid as a bioinformatic tool , 2004, Parallel Comput..

[28]  W. Graham Richards,et al.  Virtual screening using grid computing: the screensaver project , 2002, Nature Reviews Drug Discovery.

[29]  Paul D Lyne,et al.  Structure-based virtual screening: an overview. , 2002, Drug discovery today.

[30]  S. Guatelli,et al.  Biomedical applications on the GRID: efficient management of parallel jobs , 2004, IEEE Symposium Conference Record Nuclear Science 2004..

[31]  Fabrizio Gagliardi,et al.  Building an infrastructure for scientific Grid computing: status and goals of the EGEE project , 2005, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[32]  Yi Guan,et al.  Oseltamivir resistance during treatment of influenza A (H5N1) infection. , 2005, The New England journal of medicine.

[33]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.